✦ LIBER ✦

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa

✍ Scribed by E.J. Giamarellos-Bourboulis; E. Pelekanou; A. Antonopoulou; H. Petropoulou; F. Baziaka; V. Karagianni; N. Stavrianeas; H. Giamarellou

Book ID: 108669851
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 128 KB
Volume: 158
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2007.08372.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II, Open-Label Study of the Effi

A Phase II, Open-Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma

✍ Catherine C. McCuaig; Josée Dubois; Julie Powell; Claude Belleville; Michèle Dav 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Efficacy and safety of azithromycin for

Efficacy and safety of azithromycin for uncomplicated typhoid fever: An open label non-comparative study

✍ Anju Aggarwal; Apurba Ghosh; Sunil Gomber; Monjori Mitra; A. O. Parikh 📂 Article 📅 2011 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 86 KB

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study

✍ D. Rigopoulos; S. Gregoriou; A. Stratigos; G. Larios; C. Korfitis; D. Papaioanno 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Safety and Efficacy of a Milk-derived Ex

Safety and Efficacy of a Milk-derived Extract in the Treatment of Plaque Psoriasis:An Open-label Study

✍ Y. Poulin; Y. Pouliot; E. Lamiot; N. Aattouri; S. F. Gauthier 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Efficacy of Ketamine in Anesthetic Dosag

Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study

✍ Ralph-Thomas Kiefer; Peter Rohr; Annette Ploppa; Hans-Jürgen Dieterich; John Gro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Preliminary observations of oral nicotin

Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance

✍ John Robert Ingram; John Rhodes; Brian K Evans; Dr. Gareth A. O. Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Background: Transdermal nicotine provides benefit in active ulcerative colitis but is often associated with adverse events (aes). an oral formulation has been developed to minimize aes. this study was undertaken to make initial observations on the safety and tolerance of oral nicotine therapy in